» Articles » PMID: 9516143

Somatic Hypermutation, Clonal Diversity, and Preferential Expression of the VH 51p1/VL Kv325 Immunoglobulin Gene Combination in Hepatitis C Virus-associated Immunocytomas

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1998 Apr 18
PMID 9516143
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

A high prevalence of chronic hepatitis C virus (HCV) infection has recently been shown in a subset of B-cell non-Hodgkin's lymphomas, most of which belong to the lymphoplasmacytoid lymphoma/immunocytoma subtype and are characterized by the production of a monoclonal IgM cryoglobulin with rheumatoid factor activity. To better define the stage of differentiation of the malignant B cell and to investigate the role of chronic antigen stimulation in the pathogenesis of the HCV-associated immunocytomas, we analyzed the variable (V) region gene repertoire in 16 cases with this type of tumor. The lymphoma-derived V gene sequences were successfully determined in 8 cases; 5 of them expressed the 51p1 VH gene in combination with the kv325 VL gene. Moreover, a monoclonal 51p1-expressing B-cell population was detected in 4 of the remaining immunocytomas by an allele-specific Ig gene fingerprinting assay, indicating that HCV-associated immunocytomas represent clonal proliferations of a highly selected B-cell population. Somatic mutations and intraclonal diversity were observed in all of the lymphoma V genes, and clonally related IgM and IgG VH transcripts indicative of isotype switching were present in one case. These findings are consistent with an antigen-driven process and support a role for chronic antigen stimulation in the growth and clonal evolution of HCV-associated immunocytomas.

Citing Articles

Hepatitis Virus-associated Non-hodgkin Lymphoma: Pathogenesis and Treatment Strategies.

Zhang W, Du F, Wang L, Bai T, Zhou X, Mei H J Clin Transl Hepatol. 2023; 11(5):1256-1266.

PMID: 37577221 PMC: 10412707. DOI: 10.14218/JCTH.2022.00079S.


Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases.

Yu Y, Shi X, Wang X, Zhang P, Bai O, Li Y Cell Biosci. 2022; 12(1):30.

PMID: 35279210 PMC: 8917635. DOI: 10.1186/s13578-022-00763-0.


Extranodal Diffuse Large B-Cell Lymphoma of Bone and Soft Tissue Presenting With Marked Lymphedema and Hypercalcemia.

Shabbir A, Kojadinovic A, Gidfar S, Mundi P Cureus. 2022; 14(2):e22025.

PMID: 35155052 PMC: 8823701. DOI: 10.7759/cureus.22025.


Hepatitis C Virus Epitope Immunodominance and B Cell Repertoire Diversity.

Brasher N, Adhikari A, Lloyd A, Tedla N, Bull R Viruses. 2021; 13(6).

PMID: 34070572 PMC: 8229270. DOI: 10.3390/v13060983.


Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies.

Efremov D, Turkalj S, Laurenti L Cancers (Basel). 2020; 12(6).

PMID: 32481736 PMC: 7352865. DOI: 10.3390/cancers12061396.